Hikma Pharmaceutical | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Almirall EUR 377.1M 47.69M 2024-12
AstraZeneca USD 5.23B 258M 2025-03
Bayer EUR 4.02B 2.18B 2025-03
Fresenius EUR 2.39B 105M 2025-03
Galapagos EUR 108.07M 43.83M 2025-03
Genmab DKK 1.62B 8.24B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
GRIFOLS EUR 752.82M 226.96M 2025-03
Hikma Pharmaceutical USD 0 1000K 2024-06
Lonza CHF 1.11B 286M 2024-12
Merck EUR 2.15B 1.01B 2024-12
Orion EUR 259.4M 53.8M 2025-03
Recordati EUR 333.04M 98.02M 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
UCB EUR 1.57B 1.14B 2024-12



Hikma Pharmaceutical Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.